N-acetylglucosaminyltransferase V proteins and coding sequences

Overview

Information

Number
6015701
Application
08/276968
Filing date
07/19/1994
Issue date
01/18/2000
Inventor(s)
James Michael Pierce, Mohamed G. Shoreibah, Beverly Adler, Nevis Lee Fregien
US Classification
435/193; 435/252.3; 435/252.33; 435/320.1; 435/325; 536/23.2
View at USPTO

Citations

Regents of the University of California, The (1)

Abstract

Abstract

The present invention provides substantially purified UDP-N-acetylglucosamine: .alpha.-6-D-mannoside .beta.-1,6-N-acetylglucosaminyl transferase (GlcNAc T-V; EC 2.4.1.155) proteins and antibodies which specifically bind GlcNAc T-V. The present invention also provides polynucleotide sequences and oligonucleotide probes capable of specifically hybridizing to nucleic acid sequences which encode GlcNAc T-V, and cDNA and genomic clones encoding GlcNAc T-V, as well as nucleotide sequences encoding GlcNAc T-V, as specifically exemplified by GlcNAc T-V coding sequences from rat, hamster, mouse and human.

Assignees with Similar Patents

Referenced by

UNIVERSITY OF GEORGIA, THE (2)
GLYCODesign (1)
NAUREX (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
435 193 Emerging Average Seminal Medium High Slow 91.0
435 252.3 Emerging Average Average Medium Slow 89.2
435 252.33 Emerging Average Average Medium Slow 90.3
435 320.1 Emerging Average Average Medium Slow 86.9
435 325 Emerging Average Average Medium High Slow 84.5
536 23.2 Emerging Average Average Medium Slow 89.5